Tonix Pharmaceuticals Holding (TNXP) Shares Outstanding (2019 - 2026)

Tonix Pharmaceuticals Holding's Shares Outstanding (Entity) history runs 4 years deep, the most recent figure standing at $5325.0 for Q4 2023.

• On a quarterly basis, Shares Outstanding (Entity) rose 197.99% year-over-year to $5325.0 in Q4 2023; TTM through Dec 2023 was $5325.0, a 197.99% increase from a year earlier, with the FY2023 full-year figure at $5325.0, up 197.99% from the prior year.
• Shares Outstanding (Entity) eased to $5325.0 in Q4 2023 per TNXP's latest filing, from $5551.0 in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $5551.0 in Q3 2023 and bottomed at $148.0 in Q4 2020.
• The 4-year median for Shares Outstanding (Entity) is $992.0 (2022), against an average of $1849.9.
• Across the five-year window, Shares Outstanding (Entity) soared 280.41% in 2021 and jumped 70.75% in 2022, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $148.0 in 2020, then surged by 280.41% to $563.0 in 2021, then soared by 217.41% to $1787.0 in 2022, then surged by 197.99% to $5325.0 in 2023.
• Per Business Quant, the three latest TNXP Shares Outstanding (Entity) figures stand at $5325.0 (Q4 2023), $5551.0 (Q3 2023), and $3363.0 (Q2 2023).